In this episode of the Change Life Destiny Podcast, Stephanie sits down with Dr. Pejman Pirmoradi, PharmD, of Elysium Pharmaceuticals, a clinical pharmacy specialist with roughly three decades of experience in pharmacotherapy, geriatric pharmacy, hospital pharmacy, and pharmaceutical compounding.
Dr. Pirmoradi explains why he believes peptide therapy represents a fundamental shift in healthcare, moving from simply managing disease toward supporting the body's own biological processes and prioritizing healthspan, not just lifespan.
But as interest in peptides grows, so does a major concern.
Dr. Pirmoradi discusses the distinction he makes between research-only and pharmaceutical-grade peptides, why purity percentages do not necessarily tell the entire story, and why sourcing, compounding conditions, formulation, pH, temperature, preservatives, and professional oversight all matter.
The conversation also dives into the emerging science of longevity and cellular aging. Dr. Pirmoradi discusses epigenetic reprogramming research, the possibility of influencing biological aging, and why he believes medicine is entering an entirely new era.
He also shares Elysium's work developing peptide formulations and supporting clinicians with protocols, education, and pharmaceutical expertise, including discussion of emerging research involving spinal cord injury.
In this episode, we explore:
- Why Dr. Pirmoradi believes peptide therapy represents a new era of medicine
- The shift from lifespan to healthspan
- How peptides act as signaling molecules in the body
- Research-only versus pharmaceutical-grade peptides
- Why "99% pure" may not tell the entire story
- Why sourcing and professional compounding standards matter
- Semax and Selank and why Dr. Pirmoradi formulates them separately
- Elysium Pharmaceuticals' approach to peptide compounding
- Supporting practitioners with protocols and drug information
- The emerging science of epigenetics and biological aging
- Dr. David Sinclair's age-reversal research discussed in the episode
- The "immortal jellyfish" and what it suggests about biological regeneration
- Emerging peptide research involving spinal cord injury
- Why Dr. Pirmoradi believes the next decade could radically change healthcare
This conversation is a fascinating look at where pharmacology, peptides, regenerative medicine, and longevity science may be heading next.
Connect with Dr. Pirmoradi
Website- https://www.elysiumpharmaceuticals.com/
LinkedIn- https://www.linkedin.com/in/pejman-pirmoradi-pharmd-bcps-bcgp-a31b4465
Change Life & Destiny is a movement to excite, engage, and educate communities about the importance of taking control of our health and wellness. We highlight the latest and greatest technologies that can restore health, prevent disease, and promote wellness, as well as practitioners who are using cutting-edge technology to help patients take control of their health.
Learn more about us here:
Website: https://www.changelifedestiny.com/
Instagram: https://www.instagram.com/changinglifedestiny/
LinkedIn: https://www.linkedin.com/company/changelifedestiny/
YouTube: https://www.youtube.com/@changelifedestiny
Facebook: https://www.facebook.com/changelifedestiny
Want to learn more? Visit our website or follow us on Instagram, Facebook Youtube, and LinkedIn.